These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12820698)

  • 1. Utility of genetic screening in hypertrophic cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations.
    Mohiddin SA; Begley DA; McLam E; Cardoso JP; Winkler JB; Sellers JR; Fananapazir L
    Genet Test; 2003; 7(1):21-7. PubMed ID: 12820698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J
    Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
    Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
    Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
    Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
    Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
    Fananapazir L; Dalakas MC; Cyran F; Cohn G; Epstein ND
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3993-7. PubMed ID: 8483915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation analysis of beta myosin heavy chain gene in hypertrophic cardiomyopathy families].
    Fan XP; Yang ZW; Feng XL; Yang FH; Xiao B; Liang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):387-92. PubMed ID: 21811976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy.
    Richard P; Charron P; Leclercq C; Ledeuil C; Carrier L; Dubourg O; Desnos M; Bouhour JB; Schwartz K; Daubert JC; Komajda M; Hainque B
    J Mol Cell Cardiol; 2000 Aug; 32(8):1575-83. PubMed ID: 10900182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
    Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP
    Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.
    Ackerman MJ; VanDriest SL; Ommen SR; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
    J Am Coll Cardiol; 2002 Jun; 39(12):2042-8. PubMed ID: 12084606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy due to beta-myosin heavy chain mutation with extreme phenotypic variability within a family.
    Keller DI; Schwitter J; Valsangiacomo ER; Landolt P; Attenhofer Jost CH
    Int J Cardiol; 2009 May; 134(3):e87-93. PubMed ID: 18374998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.